Advertisement.

Nicholas Vardy

share

It was a lousy holiday-shortened week with the Dow Jones down 1.21%, the S&P 500 falling 1.18% and the NASDAQ tumbling 1.40%. The MCSI Emerging Markets Index had a surprisingly strong week, falling only 0.38%. Headlines today are dominated by Greece’s rejection of European austerity measures. Market sentiment is negative. Investors are worried. But as […]

share

Markets closed a tough week, with the Dow Jones down 2.89%, the S&P 500 falling 2.88% and NASDAQ tumbling 3.36%. Global stock markets fared worse, with the MCSI Emerging Markets Index down 3.46%. Despite the sharp sell-off, two positions — Markel Corp. (MKL) and Illumina Inc. (ILMN) — hit new 52-week highs. You were stopped […]

A trader looks at a mixed financial picture
share

After six months of markets locked in a narrow trading range, U.S. investors finally have awoken from their apathetic slumber.

share

Stock markets across the globe bounced strongly over the past week. The Dow Jones was up 1.34%, the S&P 500 rose 1.33% and the NASDAQ jumped 2.07%. The MCSI Emerging Markets Index recovered a strong 3.16%. Big gainers in your Alpha Investor Letter portfolio included the Market Vectors Biotech ETF (BBH), jumping 4.94%; Allergan, Inc. […]

[Greece]
share

Master speculator George Soros’ most famous trade was the one that “broke the Bank of England.” That was when the British pound exited the European Exchange Rate mechanism in September 1992. Soros reportedly made $1 billion that day after encouraging his then-CIO Stan Druckenmiller to leverage up the trade, famously telling him, “It takes courage to […]

share

It was a positive week for U.S. stock markets, with the Dow Jones up 0.65%, the S&P 500 rising 0.76% and the NASDAQ up 1.30%. The MCSI Emerging Markets Index fell 0.45%. Big gainers in your Bull Market Alert portfolio included Qualys, Inc. (QLYS), which jumped 13.94%, and the ProShares Ultra Nasdaq Biotechnology ETF (BIB), […]

X
Are YOU Ready for the Biden Disaster Plan?
"...It's worse than you think."
—Dr. Mark Skousen